Form 8-K - Current report:
SEC Accession No. 0001193125-24-268404
Filing Date
2024-12-02
Accepted
2024-12-02 07:30:32
Documents
21
Period of Report
2024-12-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d169582d8k.htm   iXBRL 8-K 131487
6 GRAPHIC g169582g04a04.jpg GRAPHIC 88998
7 GRAPHIC g169582g05a05.jpg GRAPHIC 63557
8 GRAPHIC g169582g06a06.jpg GRAPHIC 64872
9 GRAPHIC g169582g08a08.jpg GRAPHIC 94303
10 GRAPHIC g169582g09a09.jpg GRAPHIC 63586
11 GRAPHIC g169582g10a10.jpg GRAPHIC 62140
12 GRAPHIC g169582g12a12.jpg GRAPHIC 80964
  Complete submission text file 0001193125-24-268404.txt   1449940

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rvmdw-20241202.xsd EX-101.SCH 3910
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvmdw-20241202_def.xml EX-101.DEF 13293
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmdw-20241202_lab.xml EX-101.LAB 21819
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmdw-20241202_pre.xml EX-101.PRE 14197
23 EXTRACTED XBRL INSTANCE DOCUMENT d169582d8k_htm.xml XML 5751
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 241517414
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)